3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Melanoma
23
Multiple Myeloma
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Thyroid Neoplasms
8
Glioma
8
Neoplasm Metastasis
7
Hematologic Neoplasms
6
Thyroid Carcinoma, Anaplastic
5
Pancreatic Neoplasms
5
Lymphoma
5
Thyroid Cancer, Papillary
4
Neurofibromatosis 1
4
Neoplasms
4
Lung Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Adenocarcinoma, Follicular
3
Skin Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neurofibroma, Plexiform
2
Leukemia, Myelomonocytic, Juvenile
2
Histiocytosis, Langerhans-Cell
2
Glioblastoma
2
Colonic Neoplasms
2
Advanced Solid Tumors
2
Uveal Melanoma
1
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Cisplatin
13
pembrolizumab
10
Radiotherapy, Intensity-Modulated
9
Carboplatin
9
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Cetuximab
7
Radiotherapy
5
Radiation
5
Paclitaxel
5
Biopsy
5
Taxes
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
Docetaxel
3
ipatasertib
2
durvalumab
2
X-Rays
2
Surgical Procedures, Operative
2
Standard of Care
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Disulfides
2
Chemoradiotherapy
2
trametinib
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
trametinib
×
1 year
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled